Tracheobronchomalacia is a condition marked by weakened and excessively flexible airway walls, resulting in airway collapse, especially during expiration. This structural abnormality can lead to chronic cough, wheezing, recurrent respiratory infections, and exercise intolerance. The condition may be congenital or acquired due to prolonged intubation, inflammation, or external compression from masses or vascular anomalies. Diagnosis relies on dynamic imaging, bronchoscopy, and pulmonary function testing to evaluate airway collapsibility and determine the severity of obstruction.
Management focuses on improving airway stability and alleviating symptoms. Mild cases may benefit from conservative strategies such as airway clearance techniques, breathing exercises, and optimization of underlying respiratory conditions. Moderate to severe cases may require interventions like continuous positive airway pressure (CPAP), airway stenting, or surgical reconstruction to restore patency and prevent complications. Pulmonary rehabilitation and infection prevention strategies support long-term outcomes. Multidisciplinary collaboration among pulmonologists, thoracic surgeons, and respiratory therapists ensures individualized treatment planning. Advances in minimally invasive stenting, customized surgical approaches, and supportive therapies have improved patient outcomes and quality of life. Patient education regarding symptom monitoring and adherence to therapeutic interventions is also a key component of effective tracheobronchomalacia management.
Title : Global warming and increasing respiratory illnesses
Yazdan Mirzanejad, University of British Columbia, Canada
Title :
Saurabh Chattopadhyay, University of Kentucky, United States
Title : Risk factors for mycobacterium avium complex infections in patients with chronic obstructive pulmonary disease
Alizaman Sadigov, Medical University, United States
Title : Managing integration and interoperability in transformed pulmonology, respiratory medicine and lung health ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Oncology (PPO) to be set up via precision oncology strategy for cancer care team: Developing targeted lung cancer therapy and advancing personalized cancer care
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Advancements in pulmonology and respiratory care through the view of Personalized and Precision Medicine (PPM) and biodesign-driven translational applications
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation